Hemopoiesis
Title
Date Published
Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
June 10, 2008
Adverse consequences with use of erythropoiesis-stimulating agents in anemia prompt release of guidelines to ensure safe use and maximize benefit.
June 1, 2008
Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
May 31, 2008
Pharmacodynamics and Pharmacokinetics of the Novel Thrombopoietin Mimetic Peptide RWJ-800088 in Humans.
May 21, 2008
Iron regulation and erythropoiesis.
May 15, 2008
Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
May 1, 2008
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
May 1, 2008
Developments in the therapeutic use of erythropoiesis stimulating agents.
May 1, 2008
Erythropoietins should be used according to guidelines.
May 1, 2008
Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
May 1, 2008
Perioperative anaemia management: consensus statement on the role of intravenous iron.
May 1, 2008
Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants.
May 1, 2008
Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.
April 22, 2008
The use of intravenous iron in patients with cancer-related anaemia.
April 10, 2008
Thrombosis with Erythropoietic Stimulating Agents – Does Iron-Deficient Erythropoiesis Play a Role?
April 6, 2008
Managing anemia in lymphoma and multiple myeloma.
April 1, 2008
Should intravenous iron be the standard of care in oncology?
April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.
April 1, 2008
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia.
April 1, 2008
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
March 31, 2008